Opus Genetics
Sarah Callahan is a seasoned professional in clinical operations with a robust background in various senior leadership roles. Currently serving as Senior Director of Clinical Operations at Opus Genetics since March 2025, Sarah has previously held similar positions at Peachtree BioResearch Solutions and Lexitas Pharma Services, showcasing extensive experience in managing clinical operations. Prior to these roles, Sarah's career included a position as Director of Clinical Operations at Renovion, Inc., and tenure at Lexitas Pharma Services in multiple capacities, including Director, Therapeutic Area Lead, and Clinical Study Manager. Sarah began the career as a Clinical Research Associate and progressed through roles at Synteract and Inspire. Sarah holds a Master of Science in Clinical Research from Campbell University and a Bachelor of Science in Biology from the University of North Carolina at Chapel Hill.
This person is not in any teams
This person is not in any offices
Opus Genetics
Opus Genetics is a patient-first, science-driven gene therapy company tackling manufacturing obstacles standing in the way of treatments for ultra-rare blinding conditions.